Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

被引：53

作者：

Krug, LM

Miller, VA

Kalemkerian, GP

Kraut, MJ

Ng, KK

Heelan, RT

Pizzo, BA

Perez, W

McClean, N

Kris, MG

机构：

[1] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Div Solid Tumor Oncol,Thorac Oncol Serv, New York, NY 10021 USA

[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷 / 02期

关键词：

dolastatin-10; non-small-cell lung cancer;

D O I：

10.1023/A:1008349209956

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：227 / 228

页数：2

共 9 条

[1] DOLASTATIN-10, A POWERFUL CYTOSTATIC PEPTIDE DERIVED FROM A MARINE ANIMAL - INHIBITION OF TUBULIN POLYMERIZATION MEDIATED THROUGH THE VINCA ALKALOID BINDING DOMAIN [J].

BAI, R ;

PETTIT, GR ;

HAMEL, E .

BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) :1941-1949

[2]

Haldar S, 1997, CANCER RES, V57, P229

[3]

HOLLEN PJ, 1994, CANCER-AM CANCER SOC, V73, P2087, DOI 10.1002/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO

[4]

2-X

[5] Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification [J].

Kalemkerian, GP ;

Ou, XL ;

Adil, MR ;

Rosati, R ;

Khoulani, MM ;

Madan, SK ;

Pettit, GR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) :507-515

[6] ANTINEOPLASTIC AGENTS .136. THE ISOLATION AND STRUCTURE OF A REMARKABLE MARINE ANIMAL ANTINEOPLASTIC CONSTITUENT - DOLASTATIN 10 [J].

PETTIT, GR ;

KAMANO, Y ;

HERALD, CL ;

TUINMAN, AA ;

BOETTNER, FE ;

KIZU, H ;

SCHMIDT, JM ;

BACZYNSKYJ, L ;

TOMER, KB ;

BONTEMS, RJ .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (22) :6883-6885

[7]

Pitot HC, 1999, CLIN CANCER RES, V5, P525

[8]

Tran H. T., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P306

[9]

Waud W. R., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P383

← 1 →